Rachel Gonzalez
Biochemistry, Genetics and Molecular Biology · University of Michigan
Publications
75
Citations
333
Est. group size
—
Recurring co-author estimate
Active years
47
Publishing since 1980
Typically publishes in teams of ~15 · 8% small-team papers (≤3 authors) · across 8 venues
- Population-level trends in radiation treatment of low-risk prostate cancer.
Journal of Clinical Oncology · 2026
- Morning versus afternoon administration of immune checkpoint inhibitors in metastatic non-small-cell lung cancer
Journal for ImmunoTherapy of Cancer · 2026
- Abstract 1042: MAGE-A3 and PD-L1 protein co-expression in lung cancer a look at the immune cells’ tumor microenvironment
Cancer Research · 2025
- B-346 Serum ERG Protein as a Potential Biomarker for Prostate Cancer
Clinical Chemistry · 2025
- Longitudinal assessment of the association between implementation strategy use and the uptake of hepatitis C treatment: Year 2
UNC Libraries · 2025
- Highly Specific Cas9 and Cas12a Engineering of Human T Cells for Generation of Novel Allogeneic Cell Therapies
Transplantation and Cellular Therapy · 2024
- Abstract 6845: MAGEA3 expression and secretion in MMR-MSH6 and MMR-PMS2 microsatellite-stable colorectal cancer
Cancer Research · 2024
- Abstract 6445: Exploring the relationship between PSCA and PD-L1 by a comprehensive tumor immunohistochemical analysis
Cancer Research · 2024
- Abstract 2513: MAGE-A3, MAGE-A4, and PD-L1 protein show co-expression in colon, lung and bladder cancer
Cancer Research · 2024
- Abstract 3105: Computational integration with phage library to optimize clones of DEFB4A antibodies for cancer diagnostics and therapeutics
Cancer Research · 2024
- Abstract 6824: Secretion of MAGE-A3 and MAGE-A4 in cell lines and lung cancer
Cancer Research · 2024
- Abstract 2746: MAGE-A3 co-expression with IDH1-R132H and IL-1β in colon cancer
Cancer Research · 2024
- Data from Phase IIA Trial Testing Erlotinib as an Intervention against Intraductal Pancreatic Mucinous Neoplasms
2023
- Supplementary Tables 1-5 from Plasma Biomarker Profiles Differ Depending on Breast Cancer Subtype but RANTES Is Consistently Increased
2023
- Supplementary Tables 1-5 from Plasma Biomarker Profiles Differ Depending on Breast Cancer Subtype but RANTES Is Consistently Increased
2023
- Cancer Research×17
- Annals of the Rheumatic Diseases×13
- Transplantation and Cellular Therapy×1
- Gastroenterology×1
- Immunology×1
- Weishu Wu
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Nathaniel J. Smith
Biochemistry, Genetics and Molecular Biology · Indiana University
- Jiuling Yang
Medicine · University of Michigan
- Andrew J. Gunderson
Medicine · The Ohio State University
- Daniel Kupor
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile